Key result
Bioabsorbable-polymer platinum-chromium stents show delayed arterial healing with more uncovered struts in NSTE-ACS.
Why the study?
The wide variety of drug-eluting stents used in acute coronary syndrome necessitates comparative evaluation of vascular healing, particularly the relationship between neointimal formation and stent design features.
Does the type of drug-eluting stent platform and polymer coating affect neointimal healing parameters as assessed by optical coherence tomography in patients with non-ST-segment elevation acute coronary syndrome?
Observational (n=111)
Does the type of drug-eluting stent platform and polymer coating affect neointimal healing parameters as assessed by optical coherence tomography in patients with non-ST-segment elevation acute coronary syndrome?
In NSTE-ACS patients undergoing DES implantation, patient risk factors (age, hypertension, dyslipidemia) and stent diameter significantly drive vascular healing and strut coverage on OCT, underscoring the necessity of aggressive cardiovascular risk factor modification alongside stent selection.
Systemic risk factor control may enhance stent healing in NSTE-ACS; leaves open impact on clinical outcomes.
Introduction . The wide variety of drug-eluting stents used to treat acute coronary syndrome necessitates comparative studies of vascular healing processes after their implantation. Of particular interest is the nature of neointimal formation and its relationship to stent design features. Objective . To evaluate neointimal healing parameters after implantation of different types of drug-eluting stents in patients with non-ST-segment elevation acute coronary syndrome and to identify factors influencing vascular remodeling. Materials and Methods . This prospective study included 111 patients with non-ST-segment elevation acute coronary syndrome after implantation of different types of drug-eluting stents. Depending on the type of stent implanted, the patients were divided into 4 groups: Group 1 – a cobalt-chromium stent with permanent polymer and everolimus; Group 2 – a platinum-chromium stent with bioabsorbable polymer and everolimus; Group 3 – a cobalt-chromium stent with bioabsorbable coating and sirolimus; Group 4 – a platinum-chromium stent with permanent polymer and everolimus. The patient groups were comparable in terms of key clinical and demographic parameters. For quantitative assessment of healing, optical coherence tomography (OCT) was performed in all patients after 4.3±2.3 months. A total of 54,195 struts in 111 stents were analyzed by OCT. The key evaluation criterion was the calculated «healing index». Results . Statistically significant differences were found between the groups: the highest healing index (p=0.004) and the highest number of uncovered stent struts (p=0.009) were observed in the group with platinum-chromium stents with a bioabsorbable coating. Furthermore, malapposed stent struts were more common in the groups with bioabsorbable coatings (p=0.002). Multivariate regression analysis revealed that independent predictors of the healing index were age (p=0.0006), stent diameter (p=0.003), a long history of arterial hypertension (p=0.04), and dyslipidemia (p=0.006). Further analysis demonstrated that age, hypertension, and dyslipidemia were primarily associated with the number of uncovered struts, whereas stent diameter correlated mainly with the percentage of malapposed struts. Conclusions . The degree of vascular remodeling after drug-eluting stent implantation for acute coronary syndrome does not demonstrate a fundamental relationship with the type of stent platform. Non-modifiable (age, stent diameter) and modifiable (hypertension, dyslipidemia) risk factors have the most significant impact on vascular healing, highlighting the importance of systematic cardiovascular risk management in addition to the choice of interventional strategy.
No takes yet. Share an insight, caveat, or question.
Biryukov et al. (2026) conducted an observational in Non-ST-segment elevation acute coronary syndrome (n=111). Platinum-chromium stent with bioabsorbable polymer and everolimus vs. Cobalt-chromium stent with permanent polymer and everolimus, cobalt-chromium stent with bioabsorbable coating and sirolimus, and platinum-chromium stent with permanent polymer and everolimus was evaluated on Calculated healing index via optical coherence tomography (OCT) (p=0.004). Platinum-chromium stents with bioabsorbable polymer had the highest healing index (p=0.004) and uncovered struts (p=0.009) among DES types in NSTE-ACS.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: